The Global Bio-imaging Market is driven by Rapid Technological Advancements

Pooja salve

The Global Bio-imaging Market comprises medical imaging modalities such as X-ray, ultrasound, MRI, CT scan, EEG, PET, and SPECT. Bio-imaging aids in early disease detection and effective diagnosis by capturing internal body structures. It provides high-quality images of organs, soft tissues, and bones without using invasive procedures. Bio-imaging gives physicians a detailed anatomical view, helps develop treatment plans, and guides surgeries.

The Global Bio-imaging Market is estimated to be valued at US$ 5.74 BN in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the Global Bio-imaging Market are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc., Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited., Gamma Medica Inc., Samsung Medison Co., Ltd., and Philips Healthcare. Key players are focusing on product launches and enhancing their product portfolio to gain a competitive advantage in the market. For instance, in 2021, Philips launched Incisive CT imaging and intervention platform to transform radiology workflows.

The growing incidence of cancer, cardiovascular diseases, neurological disorders is fueling the demand for advanced bio-imaging modalities globally. Bio-imaging helps detect diseases in earlier stages and facilitate timely diagnosis and treatment. Furthermore, increasing investments by governments and private organizations in the healthcare sector promise Global Bio-imaging Market Size growth over the forecast period.

The global bio-imaging market is expanding rapidly with advancements in technology. Players are focusing on emerging economies for business expansion due to increasing healthcare expenditures. Further, rising awareness regarding benefits of early disease diagnosis will boost the bio-imaging market revenue in the coming years.

Market drivers

Rapid technological advancements are the primary driver propelling the global bio-imaging market forward. Manufacturers are developing innovative imaging systems with improved imaging capabilities. For instance, multi-modality imaging systems integrate modalities like PET-CT and SPECT-CT to offer anatomical and functional details simultaneously. Additionally, AI and machine learning integration enhance image quality. Automated image analysis powered by deep learning helps radiologists with early detection. Such developments increase adoption rates and fuel market revenue.

Impact of geopolitical situation on market growth and geographical regions

The global bio-imaging market is witnessing notable changes due to shifting geopolitical dynamics across several regions. The ongoing Russia-Ukraine conflict has disrupted supply chains and business operations in Eastern Europe.sanctions imposed by Western nations on Russia are limiting technology transfer and new equipment installations in the region. This is negatively impacting the demand for bio-imaging modalities in Ukraine, Russia and other neighboring markets. Moreover, political uncertainties and stringent import regulations in countries like China and India are constraining foreign investments and collaborations in the medical technology sector. However, governments worldwide are increasingly prioritizing healthcare spending to strengthen their national medical infrastructure. This provides opportunities for market players to diversify and expand their presence across lessexploreduntapped Asian and African markets. To sustain profitable growth, companies must proactively address trade barriers and closely monitor ongoing disputes or protests affecting major end-user base. Suppliers also need alternative supply chain strategies to mitigate risks from pandemic outbreaks or territorial disputes in key material sourcing locations.

In terms of value, the North American region currently holds the largest share of global bio-imaging market primarily due to advanced healthcare facilities, rising geriatric population susceptible to chronic diseases, and growing public awareness about early disease diagnosis. However, the Asia Pacific region is emerging as the fastest growing market during the forecast period due to increasing healthcare investments, rising affordability, large patient pools, and growing medical tourism across India and Southeast Asia. China in particular is expected to witness double digit growth owing to government initiatives to modernize hospitals, expand medical insurances, and improve access to specialty diagnostic services in rural areas.

Get More Insights on Bio-Imaging Market

Pooja salve

All You Need to Know about MRI and PET/CT Scan

PET Scan Mumbai 2019-09-13

Cancer – A word that inspires terror and shock in the hearts of any human being. A disease claiming thousands of people across the globe. When not diagnosed at the right time, Cancer can wreak havoc on the lives of patients and their families, ultimately snatching a life and destroying finances and lives of family members. Patients in India have always preferred overseas cancer treatment when they can afford it; their reasoning being the availability of more doctors and amenities, and a cleaner environment abroad. However, many patients, today, prefer cancer diagnostic center in Mumbai over going abroad.

Here is why:

Mumbai at par with overseas cancer treatment

One of the biggest misconceptions most people have is that cancer treatment in India is inferior to the one available in abroad countries like USA, UK, and Germany. However, the unacknowledged truth is that India is on par with treatments overseas. We have one of the best PET CT scan centers in Mumbai that is as efficient as overseas diagnostic centers in the diagnosis and location of cancer cells in patients. Cancer survivors like director Anurag Basu, who has attended several cancer conferences and seminars abroad, stand firm on the quality of treatment in the country with several specialized and renowned doctors praising the work done in India.

Cancer treatment in India is cheaper

It is not news that Cancer is a disease that saturates both the health and wealth of a patient. No matter where you go for treatment, hospital bills will be through the roof. However, comparatively, the best cancer hospital in Mumbai charges patients lesser than most hospitals abroad. Not just Mumbai, but also across India, some hospitals provide treatments at discounted prices; making it affordable than overseas treatments. Where a simple consultation in the USA costs around $ 10,000, a cancer diagnostic center in India charges just a fraction of the cost, and entire cancer treatment can be covered under the sum in India.

The support system of home

Cancer is emotionally taxing on everyone involved, especially the patients. As such, they require all the support and care they could get. While overseas treatments may offer comfort, support is something only family member can provide. This is also something that makes most NRIs and foreign residents of Indian origin choose to seek treatment at the best cancer hospital in Mumbai, for they have family here to take care of them. Moreover, the support staff in hospitals in India are friendly and happy to assist patients with difficulty to move about, making the country a viable option for cancer treatments.

Conclusion

Cancer is a personal, familial, and financial tragedy for any patient in the world. Having access to quality treatments can make the difference between survival and death. India has proven itself, over the years, to be one of the finest countries to seek cancer treatments with the best cancer hospital in Mumbai and other cities spread across the country. It is a combination of affordability, high-quality treatment, and the able support system available here that makes Mumbai a viable option to seek cancer treatments.

Clinical Trial Imaging Market to Make Great Impact in Near Future by 2028

Oliver 2019-05-06

Imaging data has been increasingly used to support the primary endpoint for several trials in the last two decades. Clinical trial imaging is conducted for monitoring, diagnosing, guiding and detecting the treatment of diseases through imaging procedure.Traditional image collection and evaluation followed a one size fits all model which resulted in data quality and compliance issues. With technological developments, the process of collecting, analyzing, and submitting clinical trial imaging data has considerably improved. Technology enabled imaging has minimized protocol deviations and enhanced compliance, adaptability, accuracy, and consistency. The pharmaceutical industry is further exploring new treatment pathways and more sophisticated medicines. Since, technology enabled imaging can provide data that is highly relevant to clinical research, regulators are requesting more images to reliably evaluate the product’s safety and efficacy.

Get More Information Clinical Trial Imaging Market: https://www.trendsmarketresearch.com/report/sample/3086

Thus, the growing need for imaging in clinical development is driving the clinical trial imaging market. Furthermore, increasing healthcare IT spending is other factor facilitating the growth of the market.However, cost of implementing functional imaging technique is expensive. Also, lack of standardization is other factor affecting clinical trial imaging market. In spite of this, constant pressure from regulators to prove the safety and efficacy of drugs is expected to minimize the impact of this restraint during the forecast period.Clinical trial imaging market can be segmented based on type, product, modality, end-use, and region. In terms of type, the clinical trial imaging market can be segmented into screening, diagnostic, and image-guided interventional clinical trial. In terms of product, the market can be segmented into software and services.

Request For Table of Contents: https://www.trendsmarketresearch.com/report/requesttoc/3086

In terms of modality, the clinical trial imaging market can be segmented into magnetic resonance imaging, computed tomography, x-ray and ultrasound, echocardiography, positron emission tomography, and others. In terms of end-use, the market can be segmented into pharmaceutical, medical device manufacturing, contract research organization, and others.In terms of region, the clinical trial imaging market can be segmented into North America, Asia Pacific, Europe, Middle East & Africa, and South America. Among all, Asia Pacific is predicted to be the most attractive market owing to large presence of pharmaceutical & biotechnology industries as well as contract research organizations in the region.

The key players in the global clinical trial imaging market are Biomedical Systems Corp, ICON Public Limited Company, Cardiovascular Imaging Technologies, Inc., Radiant Sage, LLC, Intrinsic Imaging, LLC, IXICO PLC., Paraxel International Corporation, BioClinica, Inc., BioTelemetric, Inc., and World Care Clinical, LLC among others.

Contact Us:

One Vincent Square
Westminster, London SW1P 2PN
United Kingdom

T: +44 2033221521

Email: [email protected]

Website: https://www.trendsmarketresearch.com

Report Discription: https://www.trendsmarketresearch.com/report/clinical-trial-imaging-market

Positron Emission Tomography (PET) Scanners Market Regional Analysis And Forecast 2020-2027

Rahul Kumar Yadav 2023-08-03

The Positron Emission Tomography (PET) Scanners Market has been experiencing significant growth and advancement globally. In the regional analysis of the PET scanners market, North America has been a dominant player. Europe is another prominent Positron Emission Tomography (PET) Scanners Market. The Asia-Pacific region has emerged as a rapidly growing Positron Emission Tomography (PET) Scanners Market. The global Positron Emission Tomography (PET) Scanners Market has witnessed substantial growth across different regions.

Positron Emission Tomography (PET) Scanners: Peering into the Inner Workings of the Body

Larry Paige 2023-07-27

Positron Emission Tomography (PET) scanners have revolutionized the field of medical imaging, offering a unique window into the inner workings of the human body. One of the primary applications of Positron Emission Tomography (PET) scanners is in oncology. In neurology, PET scans have become indispensable in the evaluation of brain function and the diagnosis of neurological disorders. Furthermore, Positron Emission Tomography (PET) scanners play a vital role in cardiology. As technology continues to evolve, hybrid PET-CT and PET-MRI scanners have emerged, further enriching the capabilities of PET imaging.

Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Growth Strategies for 2028

Michael Jaikishan 2023-03-29

The brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market is expected to witness market growth at a rate of 5. The rise in the usage of brain PET-MRI systems for preclinical imaging is escalating the growth of brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market. com/reports/global-brain-positron-outflow-tomography-pet-magnetic-resonance-imaging-systems-marketAsia-Pacific dominates the brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market due to the rise in the acceptance of developed diagnostic machines in research centers and universities established. North America is projected to observe significant amount of growth in the brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market due to the rise in the incidence of neurological disorders. The major players covered in the brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market report are Siemens, Koninklijke Philips N.

Positron Emission Tomography (PET) Scanners Market: Integration of Artificial Intelligence and Machine Learning Algorithms

Ben Wood 2023-07-27

The integration of Artificial Intelligence (AI) and Machine Learning (ML) algorithms is transforming the Positron Emission Tomography (PET) Scanners market, revolutionizing the way PET scans are acquired, analyzed, and interpreted. One of the significant advantages of AI and ML in PET imaging is the optimization of scan protocols. This personalized approach to PET imaging improves patient comfort and ensures the safety of vulnerable populations. According to Coherent Market Insights, the global positron emission tomography (PET) scanners market is estimated to account for US$ 1,107. As the field of AI and ML continues to progress, their integration with Positron Emission Tomography (PET) Scanners Market is expected to advance further, optimizing imaging workflows, and expanding the clinical applications of PET in various medical specialties.

WHO TO FOLLOW